Emma Shtivelman is Chief Scientist at Cancer Commons in Los Altos, California and is a molecular and cell biologist with extensive experience in cancer biology. She received her PhD in molecular biology from the Weizmann Institute of Science in Israel. Emma then continued her postdoctoral research work as a fellow at the University of California, San Francisco (UCSF), where she researched Burkitt lymphoma and neuroblastoma.
Emma has in-depth understanding of cancer signal transduction and metabolism, cancer models in vitro and in vivo, target and drug discovery and validation, assay development, and preclinical research. She has technical expertise in many modern methods used to understand the molecular basis of human malignancies and to advance preclinical and clinical research. In addition to her other cancer research experience, Emma's research work has also included the disruption of breast and pancreatic cancers through targeting of their metabolism.